Moody’s upgrades Agnico Eagle’s rating to A3 on debt reduction
Investing.com -- Gerresheimer AG stock gained 1% after announcing a change in its chief financial officer position, with Wolf Lehmann set to replace Dr. Bernd Metzner effective September 1, 2025.
The German pharmaceutical packaging manufacturer said Dr. Metzner will depart on August 31, 2025, at his own request to pursue new professional opportunities. Lehmann brings approximately 30 years of international management experience, most recently serving as Operating Partner at private equity firm Triton.
Lehmann’s background spans finance, strategy, and corporate development across various industries including transportation, chemicals, industrial services, packaging, and pharmaceuticals. The leadership change comes as Gerresheimer faces challenges with setting and meeting financial targets.
Barclays said it expects shares to react positively to the announcement.
The company has also postponed its Capital Markets Day originally scheduled for October 15, with a new date to be announced later. Market observers note this postponement likely relates to the upcoming leadership transition.
The management change follows a period during which the company has faced criticism for overly optimistic forecasts followed by guidance cuts, potentially signaling a shift in financial strategy and investor communications.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.